Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 30.00 | |
100 mg | In stock | $ 47.00 | |
200 mg | In stock | $ 72.00 | |
500 mg | In stock | $ 147.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 31.00 |
Description | Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
Synonyms | SKF96022 sodium hydrate, BY1023 (sodium hydrate), SKF96022 (sodium hydrate) |
Molecular Weight | 432.37 |
Formula | C16H14F2N3NaO4S·3/2H2O |
CAS No. | 164579-32-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.23 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pantoprazole Sodium Hydrate 164579-32-2 Apoptosis Autophagy Membrane transporter/Ion channel Proton pump Potassium Channel SKF96022 sodium Inhibitor stability orally A431 Doxorubicin BY1023 anti-secretory Pantoprazole sodium sodium Hydrate release Proton Pump SKF96022 sodium hydrate H+/K+-ATPase BY1023 sodium BY1023 (sodium hydrate) BY 1023 SKF96022 exosome MCF-7 SKF-96022 anti-ulcer SKF96022 (sodium hydrate) inhibit BY-1023 PPI SKF 96022 SKF96022 sodium Hydrate inhibitor